Entrar/Registro  
HOME SPANISH
 
Acta Pediátrica de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Acta Pediátrica de México >Year 2005, Issue 6


Hernández-Bautista V, Yamazaki-Nakashimada MA
Why three bolus of methylprednisolone?
Acta Pediatr Mex 2005; 26 (6)

Language: Español
References: 9
Page: 297-298
PDF: 22.93 Kb.


Full text




Text Extraction

No Abstract


Key words: No keywords


REFERENCIAS

  1. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharm 1999;58:363-9.

  2. Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions. Arthritis Rheum 1998;41:761-7.

  3. Buttgereit F, Da Silva JA, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 2002;61:718-22.

  4. Mandell B. Acute Rheumatoid and Immunological Diseases: management of the critically ill patient. Marcel Dekker Inc. 1994;pp527-39.

  5. Hirschberg T, Randazzo B, Hirschberg H. Effects of methylprednisolone on the in vivo induction and function on suppressor cells in man. Scand J Immunol 1980;12:33.

  6. Alvarez Valdes A. ¿Qué sabemos de la Biblia? Ed. Lumen 1995;pp5-8.

  7. Keeene M. Cristianismo. Altea, Taurus, Alfaguara 2002;p44.

  8. Cerisier A, Dacosta A, Brulport V, et al. Severe coronary events and corticoids bolus. An update apropos of 3 new cases. Arch Mal Coeur Vaiss 1997;90:1285-8.

  9. Guillen EL, Ruiz AM, Bugallo JB. Hypotension, bradycardia, and asystole after high dose methylprednisolone in a monitored patient. Am J Kidney Dis 1998;32:e4.






>Journals >Acta Pediátrica de México >Year 2005, Issue 6
 

· Journal Index 
· Links 






       
Copyright 2019